Prevalence of SARS-CoV-2 Infection among Children and Adults in 15 US Communities, 20211

Details

• Alternative Title:
  Emerg Infect Dis
• Personal Author:
  Justman, Jessica ; Skalland, Timothy ; Moore, Ayana ; Amos, Christopher I. ; Marzinke, Mark A. ; Zangeneh, Sahar Z. ; Kelley, Colleen F. ; Singer, Rebecca ; Mayer, Stockton ; Hirsch-Moverman, Yael ; Doblecki-Lewis, Susanne ; Metzger, David ; Barranco, Elizabeth ; Ho, Ken ; Marques, Ernesto T.A. ; Powers-Fletcher, Margaret ; Kissinger, Patricia J. ; Farley, Jason E. ; Knowlton, Carrie ; Sobieszczyk, Magdalena E. ; Swaminathan, Shobha ; Reed, Domonique ; Tapsoba, Jean De Dieu ; Emel, Lynda ; Bell, Ian ; Yuhas, Krista ; Schrumpf, Leah ; Mkumba, Laura ; Davis, Jontraye ; Lucas, Jonathan ; Piwowar-Manning, Estelle ; Ahmed, Shahnaz
• Corporate Authors:
  CoVPN 5002 COMPASS Study Team
• Description:
  During January-August 2021, the Community Prevalence of SARS-CoV-2 Study used time/location sampling to recruit a cross-sectional, population-based cohort to estimate SARS-CoV-2 seroprevalence and nasal swab sample PCR positivity across 15 US communities. Survey-weighted estimates of SARS-CoV-2 infection and vaccine willingness among participants at each site were compared within demographic groups by using linear regression models with inverse variance weighting. Among 22,284 persons >2 months of age and older, median prevalence of infection (prior, active, or both) was 12.9% across sites and similar across age groups. Within each site, average prevalence of infection was 3 percentage points higher for Black than White persons and average vaccine willingness was 10 percentage points lower for Black than White persons and 7 percentage points lower for Black persons than for persons in other racial groups. The higher prevalence of SARS-CoV-2 infection among groups with lower vaccine willingness highlights the disparate effect of COVID-19 and its complications.
• Subjects:
  Adult Child COVID-19/epidemiology Cross-Sectional Studies Humans Prevalence SARS-CoV-2 Seroepidemiologic Studies Vaccines
• Keywords:
  2019 Novel Coronavirus Disease Community Surveys Coronavirus Disease Epidemiology Respiratory Infections Severe Acute Respiratory Syndrome Coronavirus 2 Surveys And Questionnaires Time/Location Sampling Viruses Zoonoses
• Source:
  Emerg Infect Dis. 2024; 30(2):245-254
• Pubmed ID:
  38270128
• Pubmed Central ID:
  PMC10826749
• Document Type:
  Journal Article
• Funding:
  T32 AI114398/AI/NIAID NIH HHSUnited States/ ; UM1 AI068613/AI/NIAID NIH HHSUnited States/ ; UM1 AI068617/AI/NIAID NIH HHSUnited States/ ; UM1 AI068619/AI/NIAID NIH HHSUnited States/
• Place as Subject:
  United States
• Volume:
  30
• Issue:
  2
• Collection(s):
  Emerging Infectious Diseases
• Main Document Checksum:
  urn:sha256:bd0c3f7e8311c850a675537477741846035c154c2410b05ea5e58fed6596f18a
• Download URL:
  https://stacks.cdc.gov/view/cdc/147355/cdc_147355_DS1.pdf
• File Type:
  [PDF - 2.24 MB ]